{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:40:11Z","timestamp":1761993611047,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["heartrhythmcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HeartRhythm Case Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.hrcr.2022.12.011","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T20:11:37Z","timestamp":1670962297000},"page":"185-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["First case report of anamorelin-induced fatal arrhythmia complicated by sinus arrest and refractory ventricular tachycardia"],"prefix":"10.1016","volume":"9","author":[{"given":"Keisuke","family":"Kojima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrcr.2022.12.011_bib1","doi-asserted-by":"crossref","first-page":"1385138","DOI":"10.1155\/2020\/1385138","article-title":"Physiological effect of ghrelin on body systems","volume":"2020","author":"Akalu","year":"2020","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.hrcr.2022.12.011_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hrcr.2022.12.011_bib3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cncr.31128","article-title":"Anamorelin (ONO-7643) for the treatment of patients with non\u2013small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)","volume":"124","author":"Katakami","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.hrcr.2022.12.011_bib4","article-title":"Refractory monomorphic ventricular tachycardia induced by anamorelin","author":"Sakagami","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.hrcr.2022.12.011_bib5","first-page":"212","article-title":"Two cases of wide QRS complex tachycardia caused by anamorelin","volume":"26","author":"Okidono","year":"2022","journal-title":"J Cardiol Cases"},{"key":"10.1016\/j.hrcr.2022.12.011_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13539-014-0159-5","article-title":"Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile","volume":"5","author":"Pietra","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.hrcr.2022.12.011_bib7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrcr.2022.12.011_bib8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/01.CIR.80.4.1063","article-title":"Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapy","volume":"80","author":"Levine","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.hrcr.2022.12.011_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1254\/fpj.21046","article-title":"Pharmacological profile and clinical efficacy of anamorelin HCl (ADLUMIZ\u00aeTablets), the first orally available drug for cancer cachexia with ghrelin-like action in Japan","volume":"156","author":"Nakanishi","year":"2021","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"10.1016\/j.hrcr.2022.12.011_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.105.580811","article-title":"Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction","volume":"113","author":"Bezzina","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrcr.2022.12.011_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/32675","article-title":"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation","volume":"392","author":"Chen","year":"1998","journal-title":"Nature"}],"container-title":["HeartRhythm Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214027122002536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214027122002536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:35:17Z","timestamp":1761993317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214027122002536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2214027122002536"],"URL":"https:\/\/doi.org\/10.1016\/j.hrcr.2022.12.011","relation":{},"ISSN":["2214-0271"],"issn-type":[{"type":"print","value":"2214-0271"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First case report of anamorelin-induced fatal arrhythmia complicated by sinus arrest and refractory ventricular tachycardia","name":"articletitle","label":"Article Title"},{"value":"HeartRhythm Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrcr.2022.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}